RAPTOR PHARMACEUTICAL CORP's ticker is RPTP and the CUSIP is 75382F106. A total of 60 filers reported holding RAPTOR PHARMACEUTICAL CORP in Q2 2013. The put-call ratio across all filers is 3.65 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $982,000 | +67.0% | 109,460 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $588,000 | +16.7% | 109,460 | 0.0% | 0.00% | – |
Q1 2016 | $504,000 | -20.0% | 109,460 | -9.7% | 0.00% | -100.0% |
Q4 2015 | $630,000 | -14.1% | 121,160 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $733,000 | -61.7% | 121,160 | -0.1% | 0.00% | -50.0% |
Q2 2015 | $1,915,000 | +60.8% | 121,300 | +10.7% | 0.00% | +100.0% |
Q1 2015 | $1,191,000 | +3.3% | 109,600 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $1,153,000 | +9.7% | 109,600 | 0.0% | 0.00% | 0.0% |
Q3 2014 | $1,051,000 | -17.0% | 109,600 | 0.0% | 0.00% | 0.0% |
Q2 2014 | $1,266,000 | +15.3% | 109,600 | -0.2% | 0.00% | 0.0% |
Q1 2014 | $1,098,000 | -23.1% | 109,837 | +0.2% | 0.00% | 0.0% |
Q4 2013 | $1,427,000 | -11.6% | 109,600 | +1.4% | 0.00% | -50.0% |
Q3 2013 | $1,615,000 | +159.2% | 108,100 | +62.1% | 0.00% | +100.0% |
Q2 2013 | $623,000 | – | 66,683 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Broadfin Capital, LLC | 7,000,000 | $32,200,000 | 3.11% |
SV Health Investors, LLC | 888,132 | $4,085,000 | 3.05% |
Sarissa Capital Management LP | 2,725,000 | $12,535,000 | 2.76% |
GREAT POINT PARTNERS LLC | 1,346,344 | $6,193,000 | 2.22% |
Virtus ETF Advisers LLC | 126,869 | $584,000 | 0.80% |
SPHERA FUNDS MANAGEMENT LTD. | 400,000 | $1,840,000 | 0.40% |
TFS CAPITAL LLC | 459,546 | $2,114,000 | 0.30% |
GLOBEFLEX CAPITAL L P | 238,239 | $1,096,000 | 0.29% |
TURNER INVESTMENTS LLC | 161,100 | $741,000 | 0.20% |
Birchview Capital, LP | 40,000 | $184,000 | 0.13% |